Correlation Between YS Biopharma and Regen BioPharma
Can any of the company-specific risk be diversified away by investing in both YS Biopharma and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining YS Biopharma and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between YS Biopharma Co, and Regen BioPharma, you can compare the effects of market volatilities on YS Biopharma and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in YS Biopharma with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of YS Biopharma and Regen BioPharma.
Diversification Opportunities for YS Biopharma and Regen BioPharma
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between YS Biopharma and Regen is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding YS Biopharma Co, and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and YS Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on YS Biopharma Co, are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of YS Biopharma i.e., YS Biopharma and Regen BioPharma go up and down completely randomly.
Pair Corralation between YS Biopharma and Regen BioPharma
If you would invest 48.00 in YS Biopharma Co, on September 1, 2024 and sell it today you would earn a total of 0.00 from holding YS Biopharma Co, or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 4.55% |
| Values | Daily Returns |
YS Biopharma Co, vs. Regen BioPharma
Performance |
| Timeline |
| YS Biopharma Co, |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Regen BioPharma |
YS Biopharma and Regen BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with YS Biopharma and Regen BioPharma
The main advantage of trading using opposite YS Biopharma and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if YS Biopharma position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.| YS Biopharma vs. Revelation Biosciences | YS Biopharma vs. Cardio Diagnostics Holdings | YS Biopharma vs. Biodexa Pharmaceticals | YS Biopharma vs. ZyVersa Therapeutics |
| Regen BioPharma vs. Therapeutic Solutions International | Regen BioPharma vs. Alpha Cognition | Regen BioPharma vs. Regen BioPharma | Regen BioPharma vs. Vg Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |